SE436751B - PROCEDURE IN accordance with Claim 1 of Patent 7613920-3 (PUBL. No. 423903) FOR PREPARATION OF 17ALFA-ACYLOXI-9ALFA, 21-DIHALOGEN-11BETA-HYDROXI-6ALFA-FLUOR-16BETA-METHYL-PREGNA 20-dione COMPOUNDS - Google Patents

PROCEDURE IN accordance with Claim 1 of Patent 7613920-3 (PUBL. No. 423903) FOR PREPARATION OF 17ALFA-ACYLOXI-9ALFA, 21-DIHALOGEN-11BETA-HYDROXI-6ALFA-FLUOR-16BETA-METHYL-PREGNA 20-dione COMPOUNDS

Info

Publication number
SE436751B
SE436751B SE7706673A SE7706673A SE436751B SE 436751 B SE436751 B SE 436751B SE 7706673 A SE7706673 A SE 7706673A SE 7706673 A SE7706673 A SE 7706673A SE 436751 B SE436751 B SE 436751B
Authority
SE
Sweden
Prior art keywords
acyloxi
9alfa
6alfa
17alfa
16beta
Prior art date
Application number
SE7706673A
Other languages
Swedish (sv)
Other versions
SE7706673L (en
Inventor
J Kalvoda
G Anner
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7706673L publication Critical patent/SE7706673L/en
Publication of SE436751B publication Critical patent/SE436751B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7706673A 1976-09-29 1977-06-08 PROCEDURE IN accordance with Claim 1 of Patent 7613920-3 (PUBL. No. 423903) FOR PREPARATION OF 17ALFA-ACYLOXI-9ALFA, 21-DIHALOGEN-11BETA-HYDROXI-6ALFA-FLUOR-16BETA-METHYL-PREGNA 20-dione COMPOUNDS SE436751B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (en) 1976-09-29 1976-09-29

Publications (2)

Publication Number Publication Date
SE7706673L SE7706673L (en) 1978-03-30
SE436751B true SE436751B (en) 1985-01-21

Family

ID=19728370

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706673A SE436751B (en) 1976-09-29 1977-06-08 PROCEDURE IN accordance with Claim 1 of Patent 7613920-3 (PUBL. No. 423903) FOR PREPARATION OF 17ALFA-ACYLOXI-9ALFA, 21-DIHALOGEN-11BETA-HYDROXI-6ALFA-FLUOR-16BETA-METHYL-PREGNA 20-dione COMPOUNDS

Country Status (24)

Country Link
JP (1) JPS5356652A (en)
AT (3) AT363197B (en)
AU (1) AU514200B2 (en)
BE (1) BE859120A (en)
CA (1) CA1101410A (en)
CH (9) CH624967A5 (en)
CY (1) CY1178A (en)
DD (1) DD133150A5 (en)
DE (1) DE2743069C2 (en)
DK (1) DK146017C (en)
ES (1) ES462763A1 (en)
FR (1) FR2366311A1 (en)
GB (1) GB1563638A (en)
HK (1) HK16683A (en)
HU (1) HU175218B (en)
IE (1) IE46047B1 (en)
IL (1) IL53012A (en)
KE (1) KE3258A (en)
LU (1) LU75903A1 (en)
MY (1) MY8400092A (en)
NL (1) NL7710089A (en)
SE (1) SE436751B (en)
SG (1) SG3383G (en)
ZA (1) ZA775800B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (en) * 1978-04-05 1991-11-18 Sibla Srl 3-ACETOXY-9BETA, 11BETA-EPOXY-PREGNA-1,3,5-TRIEN, PROCESS FOR THE PREPARATION THEREOF, AND PROCESS FOR THE PREPARATION OF 6-alpha-halogen-1,4-diene-3-ones.
DE3227312A1 (en) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen NEW 6.16 DIMETHYL CORTICOIDS, THEIR PRODUCTION AND USE
EP0523132A1 (en) * 1990-03-27 1993-01-20 Schering Corporation PROCESS FOR 9$g(a)-HYDROXY STEROID DEHYDRATION
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
CA2473471A1 (en) 2001-11-29 2003-06-12 Taro Pharmaceuticals U.S.A., Inc. Method for the preparation of 6-alpha-fluoro corticosteroids
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
AU2016279801B2 (en) 2015-06-18 2021-09-09 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
AT363197B (en) 1981-07-10
BE859120A (en) 1978-03-28
CH632521A5 (en) 1982-10-15
ZA775800B (en) 1978-08-30
IE46047L (en) 1978-03-29
FR2366311A1 (en) 1978-04-28
CA1101410A (en) 1981-05-19
DK146017C (en) 1983-10-24
JPS5356652A (en) 1978-05-23
CH625809A5 (en) 1981-10-15
CY1178A (en) 1983-06-10
DK146017B (en) 1983-05-24
GB1563638A (en) 1980-03-26
HU175218B (en) 1980-06-28
AU2914877A (en) 1979-04-05
FR2366311B1 (en) 1982-12-03
DE2743069C2 (en) 1987-03-05
IL53012A (en) 1982-05-31
ES462763A1 (en) 1978-05-16
HK16683A (en) 1983-05-27
AT363203B (en) 1981-07-27
NL7710089A (en) 1978-03-31
IE46047B1 (en) 1983-02-09
SG3383G (en) 1983-09-09
AT363202B (en) 1981-07-27
CH632279A5 (en) 1982-09-30
CH625808A5 (en) 1981-10-15
ATA691077A (en) 1980-12-15
CH631999A5 (en) 1982-09-15
CH624967A5 (en) 1981-08-31
SE7706673L (en) 1978-03-30
ATA151379A (en) 1980-12-15
IL53012A0 (en) 1977-11-30
DE2743069A1 (en) 1978-03-30
JPS6214557B2 (en) 1987-04-02
ATA151279A (en) 1980-12-15
CH631998A5 (en) 1982-09-15
KE3258A (en) 1983-03-04
LU75903A1 (en) 1978-05-16
MY8400092A (en) 1984-12-31
CH632000A5 (en) 1982-09-15
DD133150A5 (en) 1978-12-13
DK256977A (en) 1978-03-30
AU514200B2 (en) 1981-01-29
CH625810A5 (en) 1981-10-15

Similar Documents

Publication Publication Date Title
IT1086515B (en) COMPLEX COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND USE
AR224095A1 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF DITIOL-1,2 TIONA-3
SE431653B (en) PROCEDURE FOR PREPARING 2,3-DIHYDRO-IMIDAZO / 2,1-B / TIAZOLD DERIVATIVES
SE436570B (en) PROCEDURE FOR PREPARING N- (5-TETRAZOLYL) -4-OXO-4H-PYRIMIDO / 2,1-B / -BENZOTIAZOL-3-CARBOXAMIDES WITH ANTI-ALLERGIC EFFECTS
NO770366L (en) PROCEDURES FOR THE PREPARATION OF META-ARYLOXY-BENZALDEHYDES.
DK314677A (en) PROCEDURES FOR THE PREPARATION OF TIC13.
SE7701459L (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 1,2-DITIOL
NO151365C (en) PROCEDURE FOR THE PREPARATION OF 4-HALOGEN-DIHYDROPYRANE DERIVATIVES.
NO149428C (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND INGREDIATES.
SE436751B (en) PROCEDURE IN accordance with Claim 1 of Patent 7613920-3 (PUBL. No. 423903) FOR PREPARATION OF 17ALFA-ACYLOXI-9ALFA, 21-DIHALOGEN-11BETA-HYDROXI-6ALFA-FLUOR-16BETA-METHYL-PREGNA 20-dione COMPOUNDS
RO78954A (en) PROCESS FOR THE PREPARATION OF GAMA-PIRONS
NL7707086A (en) PYRAZOLO (1,5-C) CHINAZOLINE DERIVATIVES AND METHODS FOR THEIR PREPARATION AND APPLICATION.
IT1083440B (en) PROCEDURE FOR THE MANUFACTURE OF FLAP HINGES
RO81681A (en) PROCEDURE FOR THE PREPARATION OF 1,2,3-TIADIAZOL-3-IN-5-ILIDENEURS
DK187577A (en) PROCEDURE FOR THE PREPARATION OF 1,4-BENZODIOX INTERVENTIVES
AR216558A1 (en) PROCEDURE FOR THE PREPARATION OF 1,3-DIHYDRO-3- (3 ', 4', 5'-TRIMETHOXY-STIRIL) -6-METHYL-7-HYDROXY-FURO- (3,4, C) -PYRIDINE
SE436026B (en) PROCEDURE FOR THE PREPARATION OF 13,14-DEHYDROPROSTAGLANDINES
RO77295A (en) PROCESS FOR THE PREPARATION OF NON-SULFENILATED OZICARBAMATE
SE423813B (en) PROCEDURE FOR THE PREPARATION OF 1,5-DISUBSTITUTED PYRROLIDONS WITH THERAPEUTICAL PROPERTIES
RO70629A (en) PROCEDURE FOR THE PREPARATION OF 3,4-DIHYDRO-2-METHYL-4-OXO-2H-1,2-BENZOTIAZINE-3-CARBOXYLIC ACID 1,1-DIOXIDE
SE7707125L (en) PROCEDURE FOR THE PREPARATION OF 7- (ALFA- (2,3, - DIHYDRO-2-OXO-1H- BENSIMIDAZOLE -1- YLCARBOMYL-AMINO) ARYLACETAMIDO) CEPHALASPORINES
DK131474B (en) Analogous process for the preparation of 9alpha-halogen-11beta, 17alpha, 21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-21-adamantane-1'-carboxylates.
SE428922B (en) PROCEDURE FOR THE PREPARATION OF 13,14-DIHYDRO-11-DIOXY-PROSTAGLANDINES
DK140728B (en) Process for the preparation of pregnane derivatives.
SE7613411L (en) PROCEDURE FOR MAKING N, N'-BIS-TRI-METHYLSILYL URBAN

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7706673-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7706673-6

Format of ref document f/p: F